ResearcherUniversity Hospital Schleswig-HolsteinActive in the last 2 years
Ulrich Friedrich Wellner
Matched on ORCID iD 0000-0002-8632-166X; OpenAlex author ID A5026516010, A5122357160. Sources: OpenAlex.
Their work
- Papers
- 47 (first author 1, last author 9)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 112
2015: 4 papers · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 8 papers · 2021: 6 papers · 2022: 4 papers · 2023: 7 papers · 2024: 6 papers · 2025: 3 papers · 2026: 2 papers
Papers 47
- Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-026-01663-z↗
- Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? Co-author DOI 10.3390/cancers18152423↗
- Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma. Last author DOI 10.1001/jamasurg.2024.5024↗
- Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. Co-author DOI 10.1001/jamasurg.2025.4054↗
- An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from the German Cancer Registry Group. Last author DOI 10.1016/j.ejso.2025.109693↗
- The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national re… Co-author DOI 10.1016/j.surg.2023.11.004↗
- Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. Co-author DOI 10.1097/xcs.0000000000000971↗
- Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Eval… Co-author DOI 10.1245/s10434-024-15932-3↗
- ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Pa… Co-author DOI 10.1245/s10434-024-16021-1↗
- RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer. Co-author DOI 10.3390/biomedicines12010199↗
- Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic D… Co-author DOI 10.3390/cancers16112016↗
- Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Co-author DOI 10.1016/j.lanepe.2023.100673↗
- Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancre… Co-author DOI 10.1016/j.surg.2023.04.042↗
- Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jclinpath-2022-208176↗
- Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations. Co-author DOI 10.3389/fonc.2023.1230382↗
- Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant… Co-author DOI 10.3390/cancers15030581↗
- TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation. Co-author DOI 10.3390/cancers15153791↗
- Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response. Co-author DOI 10.3390/cells12040587↗
- [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective]. Co-author DOI 10.1055/a-1768-1012↗
- Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. Co-author DOI 10.1097/sla.0000000000005433↗
- Suppressive Role of ACVR1/ALK2 in Basal and TGFβ1-Induced Cell Migration in Pancreatic Ductal Adenocarcinoma Cells and Identification of a Self-Perpetuating Au… Co-author DOI 10.3390/biomedicines10102640↗
- Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cance… Co-author DOI 10.3390/cancers14040868↗
- Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysis. Co-author DOI 10.1007/s00423-021-02138-4↗
- Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.11.015↗
- Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenect… Co-author DOI 10.21873/anticanres.15329↗
- A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tum… Co-author DOI 10.3390/cancers13184663↗
- Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b thro… Co-author DOI 10.3390/cancers13215541↗
- Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis. Co-author DOI 10.3791/62541↗
- Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00428-019-02719-1↗
- Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer. Co-author DOI 10.1007/s10456-020-09725-x↗
- [Indications for Surgery in Pancreatic Ductal Adenocarcinoma - Consensus Recommendations by the German Society for General and Visceral Surgery]. Co-author DOI 10.1055/a-1161-9501↗
- Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003123↗
- Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-20-0439↗
- Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology. Last author DOI 10.1371/journal.pone.0234568↗
- FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines. Co-author DOI 10.21873/anticanres.14355↗
- Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of a New Simplified Borderline Resectabilit… Last author DOI 10.3390/cancers12040882↗
- Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer. Co-author DOI 10.1016/j.cell.2019.05.012↗
- The impact of preoperative biliary stenting in pancreatic cancer: A case-matched study from the German nationwide pancreatic surgery registry (DGAV StuDoQ|Panc… Last author DOI 10.1016/j.pan.2019.09.007↗
- Kidney Transplantation after Extended Multivisceral Resection for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1155/2018/3757382↗
- HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. Co-author DOI 10.1007/s10495-016-1332-4↗
- The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors. Last author DOI 10.1016/j.tranon.2017.04.009↗
- Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer. Co-author DOI 10.1007/s00423-015-1363-2↗
- Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival. Co-author DOI 10.7150/jca.15864↗
- Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma. Last author DOI 10.1111/jgh.12752↗
- Regulation mechanisms of the hedgehog pathway in pancreatic cancer: a review. Co-author DOI 10.6092/1590-8577/2894↗
- Neoadjuvant therapy in pancreatic cancer: review article. First author DOI 10.6092/1590-8577/2940↗
- Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. Co-author PMID 26124362↗
Closest collaborators
The 25 strongest of 112 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tobias Keck · 33 shared papers, 2015–2026 · strength 4.20
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequenc… DOI 10.3390/cancers15030581↗
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Louisa Bolm · 26 shared papers, 2015–2026 · strength 3.33
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Rüdiger Braun · 20 shared papers, 2021–2026 · strength 3.31
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequenc… DOI 10.3390/cancers15030581↗
- Kim C. Honselmann · 21 shared papers, 2015–2026 · strength 2.82
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Steffen Deichmann · 14 shared papers, 2015–2026 · strength 2.00
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Hryhoriy V. Lapshyn · 14 shared papers, 2016–2026 · strength 1.84
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperativ… DOI 10.1016/j.surg.2023.04.042↗
- Hendrik Ungefroren · 8 shared papers, 2021–2024 · strength 1.39
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Paper Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequenc… DOI 10.3390/cancers15030581↗
- Paper TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent… DOI 10.3390/cancers15153791↗
- Jens Uwe Marquardt · 6 shared papers, 2022–2026 · strength 1.22
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequenc… DOI 10.3390/cancers15030581↗
- Dirk Bausch · 11 shared papers, 2015–2021 · strength 0.94
- Paper Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2020.11.015↗
- Paper Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer. DOI 10.1007/s10456-020-09725-x↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Hendrik Lehnert · 5 shared papers, 2021–2024 · strength 0.88
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Paper TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent… DOI 10.3390/cancers15153791↗
- Paper Suppressive Role of ACVR1/ALK2 in Basal and TGFβ1-Induced Cell Migration in Pancreatic Ductal Adenocarcinoma Cells and … DOI 10.3390/biomedicines10102640↗
- Thaer S. A. Abdalla · 4 shared papers, 2024–2026 · strength 0.75
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A c… DOI 10.1016/j.surg.2023.11.004↗
- Ekaterina Petrova · 7 shared papers, 2019–2022 · strength 0.73
- Paper Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2020.11.015↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Oliver Schilling · 7 shared papers, 2015–2023 · strength 0.62
- Paper Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcin… DOI 10.1136/jclinpath-2022-208176↗
- Paper Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis. DOI 10.3791/62541↗
- Paper FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lin… DOI 10.21873/anticanres.14355↗
- Lennart von Fritsch · 3 shared papers, 2024–2026 · strength 0.58
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗
- Carlos F. Fernandez-del Castillo · 5 shared papers, 2020–2024 · strength 0.57
- Paper The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A c… DOI 10.1016/j.surg.2023.11.004↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Paper FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lin… DOI 10.21873/anticanres.14355↗
- Keith D. Lillemoe · 5 shared papers, 2020–2024 · strength 0.57
- Paper The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A c… DOI 10.1016/j.surg.2023.11.004↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Paper FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lin… DOI 10.21873/anticanres.14355↗
- Natalie Petruch · 4 shared papers, 2021–2024 · strength 0.52
- Paper The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A c… DOI 10.1016/j.surg.2023.11.004↗
- Paper Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. DOI 10.1097/sla.0000000000005433↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Benedikt Färber · 3 shared papers, 2023–2026 · strength 0.52
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell p… DOI 10.3389/fonc.2023.1230382↗
- Paper Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Prec… DOI 10.3390/cells12040587↗
- Waldemar H. Uhl · 4 shared papers, 2019–2024 · strength 0.49
- Paper Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancrea… DOI 10.1245/s10434-024-15932-3↗
- Paper ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocar… DOI 10.1245/s10434-024-16021-1↗
- Paper [Indications for Surgery in Pancreatic Ductal Adenocarcinoma - Consensus Recommendations by the German Society for Gene… DOI 10.1055/a-1161-9501↗
- Bodil Andersson · 3 shared papers, 2024 · strength 0.48
- Paper Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. DOI 10.1097/xcs.0000000000000971↗
- Paper Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancrea… DOI 10.1245/s10434-024-15932-3↗
- Paper ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocar… DOI 10.1245/s10434-024-16021-1↗
- Karin U. Johansen · 3 shared papers, 2024 · strength 0.48
- Paper Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. DOI 10.1097/xcs.0000000000000971↗
- Paper Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancrea… DOI 10.1245/s10434-024-15932-3↗
- Paper ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocar… DOI 10.1245/s10434-024-16021-1↗
- Bergþór Björnsson · 3 shared papers, 2024 · strength 0.48
- Paper Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. DOI 10.1097/xcs.0000000000000971↗
- Paper Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancrea… DOI 10.1245/s10434-024-15932-3↗
- Paper ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocar… DOI 10.1245/s10434-024-16021-1↗
- Simone Augustinus · 3 shared papers, 2024 · strength 0.48
- Paper Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. DOI 10.1097/xcs.0000000000000971↗
- Paper Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancrea… DOI 10.1245/s10434-024-15932-3↗
- Paper ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocar… DOI 10.1245/s10434-024-16021-1↗
- Bobby Tingstedt · 3 shared papers, 2024 · strength 0.48
- Paper Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. DOI 10.1097/xcs.0000000000000971↗
- Paper Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancrea… DOI 10.1245/s10434-024-15932-3↗
- Paper ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocar… DOI 10.1245/s10434-024-16021-1↗
- Henry Anthony Pitt · 3 shared papers, 2024 · strength 0.48
- Paper Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. DOI 10.1097/xcs.0000000000000971↗
- Paper Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancrea… DOI 10.1245/s10434-024-15932-3↗
- Paper ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocar… DOI 10.1245/s10434-024-16021-1↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.